SAN DIEGO, Dec. 20, 2016 -- Next Generation Labs, the makers of proprietary TFN Nicotine® – a non-tobacco derived synthetic nicotine liquid – has developed a scientific method to test the authenticity of synthetic nicotine in a final e-liquid product sold commercially.
As the popularity of synthetic nicotine increases, Next Generation Labs recognized the need for a test to validate the authenticity of e-liquids claimed to be made from synthetic nicotine. The Next Generation Labs team developed a process that enables e-liquid manufacturers to test the origin of the nicotine, providing adult consumers with the confidence that they are not being sold a tobacco-nicotine as a mislabeled synthetic product.
Next Generation Labs was alerted by its trade customers to products in the market that were being sold as ‘made from synthetic nicotine’. Next Generation Labs decided it needed to validate competitor product claims and therefore developed a formal set of replicable tests that identify the presence of tobacco-derived impurities, which are not present in synthetic nicotine. Test results have revealed traces of tobacco-derived impurities in competitor brands, suggesting their claims of using synthetic nicotine or non-tobacco, may be suspect.
Vincent Schuman, CEO of Next Generation Labs comments: “For the sake of the legitimate nicotine trade, and to protect adult consumer interest, it’s critical that we put a stop to false marketing claims about synthetic nicotine – we want to protect the industry as a whole.”
“We have a responsibility to ensure adult consumers have the opportunity to try e-liquids made with true synthetic nicotine, rather than product mislabeled as such; initial response from adult vapers tells us that consumers actually prefer the taste of e-liquids made with TFN Nicotine over those made with tobacco-derived nicotine. Companies that are making false claims about using synthetic nicotine are unscrupulous and it’s important that consumers are kept informed about what’s occurring in the industry,” concludes Schuman.
Next Generation Labs sells patented TFN Nicotine® directly to e-liquid manufacturers. Please contact Vincent Schuman directly at [email protected] to purchase TFN Nicotine, or for support in testing any e-liquid to verify the use of synthetic nicotine.
*The Next Generation Labs testing methods are only applicable to e-liquids that do not contain added tobacco flavor extracts.
About Next Generation Labs
Founded in 2014, Next Generation Labs developed TFN Nicotine®, the world’s leading synthetic nicotine that is not derived from tobacco. TFN Nicotine is used in over 40 e-liquid brands in the US and is playing a central role in revolutionizing the e-cigarette and vaping industry.
www.nextgenerationlabs.com
Contacts Katie Ray [email protected] 973 570 6907 Ron Tully [email protected] 973 668 3887


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Instagram Outage Disrupts Thousands of U.S. Users
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



